Page last updated: 2024-08-17

spironolactone and dinoprostone

spironolactone has been researched along with dinoprostone in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bao, Y; Kanai, N; Lu, R; Schuster, VL; Wolkoff, AW1
Hashimoto, Y; Ibaramoto, K; Inui, KI; Masuda, S; Saito, H; Takeuchi, A1
Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Hatano, M; Honda, M1
Hatano, M; Honda, M; Izumi, Y1
Guarner, F; Medina, JF; Milazzo, A; Prieto, J; Quiroga, J1
Amir, I; Shohami, E; Weidenfeld, J1
Adiyiah, J; Bayorh, M; Eatman, D; Lyn, D; Rollins-Hairston, A1
Dagvadorj, J; Kamiya, H; Kato, K; Kato, Y; Koide, N; Komatsu, T; Kondo, M; Nakamura, J; Odkhuu, E; Watarai, A; Yokochi, T1

Other Studies

10 other study(ies) available for spironolactone and dinoprostone

ArticleYear
Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates.
    The American journal of physiology, 1996, Volume: 270, Issue:2 Pt 2

    Topics: Anion Transport Proteins; Anions; Carrier Proteins; HeLa Cells; Hormones; Humans; Hydrogen-Ion Concentration; Serum Albumin; Sodium Chloride; Solutions; Steroids; Substrate Specificity; Sucrose; Sulfobromophthalein; Taurocholic Acid; Time Factors

1996
Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney.
    Molecular pharmacology, 1999, Volume: 55, Issue:4

    Topics: Amino Acid Sequence; Animals; Base Sequence; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Kidney; Male; Membrane Proteins; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Oocytes; Organic Anion Transporters; Rats; Rats, Wistar; RNA, Messenger; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Tissue Distribution; Transfection; Xenopus laevis

1999
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Influence of spironolactone on urinary prostaglandin E2 and kinin excretion in rats.
    Prostaglandins, leukotrienes, and essential fatty acids, 1988, Volume: 31, Issue:1

    Topics: Animals; Blood Pressure; Dinoprostone; Kinins; Male; Potassium; Prostaglandins E; Rats; Rats, Inbred SHR; Sodium; Spironolactone

1988
[Influence of spironolactone on urinary prostaglandin E2 and kinin excretions in spontaneously hypertensive rats].
    Nihon Naibunpi Gakkai zasshi, 1988, Jan-20, Volume: 64, Issue:1

    Topics: Animals; Blood Pressure; Dinoprostone; Kinins; Male; Potassium; Prostaglandins E; Rats; Rats, Inbred SHR; Renin; Sodium; Spironolactone

1988
Effect of spironolactone on renal prostaglandin excretion in patients with liver cirrhosis and ascites.
    Journal of hepatology, 1986, Volume: 3, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aged, 80 and over; Ascites; Body Weight; Dinoprostone; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Prostaglandins; Prostaglandins E; Sodium; Spironolactone; Thromboxane A2

1986
Role of glucocorticoids in the regulation of brain prostaglandin biosynthesis under basal conditions and in response to endotoxin.
    Endocrinology, 1993, Volume: 132, Issue:3

    Topics: Adrenalectomy; Animals; Cerebral Cortex; Cerebral Ventricles; Dexamethasone; Dinoprostone; In Vitro Techniques; Injections, Intraventricular; Lipopolysaccharides; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Reference Values; Spironolactone

1993
Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2012, Volume: 13, Issue:3

    Topics: Acetophenones; Aldosterone; Animals; Blood Pressure; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Eplerenone; Epoprostenol; Heart Rate; Immunohistochemistry; Kidney; Male; Membrane Proteins; Rats; Rats, Inbred Dahl; Spironolactone; Systole; Vasoconstrictor Agents

2012
Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB.
    Immunopharmacology and immunotoxicology, 2014, Volume: 36, Issue:3

    Topics: Aldosterone; Animals; Cells, Cultured; Dinoprostone; I-kappa B Kinase; Inflammation Mediators; Lipopolysaccharides; Mice; NF-kappa B; Nitric Oxide; Phosphorylation; Spironolactone; Tumor Necrosis Factor-alpha

2014